February 3, 2017
TOKYO- Japan’s health ministry has approved what would be the world’s first clinical research for transplanting to a patient induced pluripotent stem, or iPS, cells made from someone else’s cells.
The plan was approved by a panel of experts at the ministry on Wednesday.
The research calls for transplanting to the retina of a person, who is suffering age-related macular degeneration, a serious eye disease, iPS-derived cells made from cells of another person. The disease could lead to blindness.
Government-affiliated research institute’s Center for Developmental Biology in Kobe, Hyogo Prefecture, western Japan, is set to produce the cells to be transplanted. (Jiji Press)
- US STATES BANNING ABORTION A VICTORY FOR CONSERVATIVE or A LOST OF WOMEN’S RIGHT
- WHO: MASS VACCINATION NOT REQUIRED FOR MONKEYPOX AT THIS TIME
- GEORGE SOROS AS UKRAINE PUPPET MASTER
- WILL MONKEYPOX BE DECLARED AS AN ‘Emergency of International Concern’ BY WHO
- WHO RUN THE WORLD? BLACKROCK?
- WAR WITH RUSSIA: US MAINSTREAM MEDIA, SELECTIVE & MISLEADING? – STEPHEN COHEN
- BILL GATES THE BIGGEST FUNDER OF WHO DR VANDAN SHIVA